DynamiCare-based program to support re-entry for stimulant users at risk for HIV
Official title: RESTORE Study R61 Pilot Phase: Recovery and Engagement for Stimulant Users on Re-entry
Run by University of Texas Southwestern Medical Center · NCT07136363 · Data updated 2026-11-12
This study tests whether adding the DynamiCare mobile app plus patient navigation helps people released from justice settings who use stimulants to start HIV care (ART/PrEP) and reduce stimulant use.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | University of Texas Southwestern Medical Center Academic / other |
| Locations | 2 sites (New Haven, Connecticut and 1 other locations) |
| Status | Recruiting |
| Started | June 1, 2026 |
| Main results expected | April 1, 2027 |
| Study ends | July 31, 2027 |
| Registry record updated | June 15, 2026 |
| Trial ID | NCT07136363 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) with stimulant use disorder (methamphetamine and/or cocaine) who are transitioning from a justice setting and are at risk for or living with HIV, willing to use a smartphone app.
✕Probably not a fit
Participants without access to a smartphone or who have unsafe medical or psychiatric conditions may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The RESTORE study will evaluate a package that combines DynamiCare, a mobile contingency management tool, with patient navigation to help individuals transitioning from jail or other justice settings. In phase R61, researchers will assess feasibility, acceptability, and preliminary effectiveness in about 40 participants, focusing on stimulant use and HIV-related outcomes. If milestones are met, the study may progress to a larger randomized phase (R33) to compare the DynamiCare-plus approach against standard supports. Participants are adults with stimulant use disorder who are at risk for or living with HIV and who are transitioning back into the community. The intervention addresses barriers such as transportation, housing, and access to HIV services by delivering behavioral incentives and support through mobile technology and navigation.
Why it matters
Potential benefit: If successful, this approach could improve uptake of ART/PrEP and reduce stimulant use among justice-involved individuals.
How similar studies have gone: Contingency management and mobile health tools have shown promise in reducing stimulant use, with some evidence of behavioral benefits, though HIV-related outcomes in justice populations remain less established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Be 18 years of age or older * Have a DSM-5 diagnosis of stimulant use disorder (methamphetamine and/or cocaine) * Be at risk for or living with HIV * Be transitioning to the community from a closed justice setting, such as: Jail Prison Justice-mandated residential substance use program * Be able to provide informed consent * Be willing and able to use a smartphone app (DynamiCare) Exclusion Criteria: * Severe medical or psychiatric disability making participation unsafe * Unable to provide consent or engage with the intervention
Where it's running
-
Yale University
New Haven, Connecticut, United States Recruiting -
Parkland County Hospital
Dallas, Texas, United States Recruiting
Study contacts
- Principal investigator: Ank Nijhawan, MD — University of Texas Southwestern Medical Center
- Study coordinator: Ank Nijhawan, MD
- Email: Ank.Nijhawan@UTSouthwestern.edu
- Phone: 2146482777
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
See if PrEP Choice helps young people start and stick with HIV prevention methods
This trial tests whether the PrEP Choice package helps 13-24 year-olds in the U.S. begin and continue using PrEP or DoxyPEP for HIV prevention.
-
PrEP Optimization Through Enhanced Continuum Tracking (PrOTECT AL)
This project will test a real-time PrEP care dashboard and implementation strategies at seven Alabama clinics to see if they increase PrEP coverage and equity among people at risk for HIV.
-
Improving HIV services for justice-involved Black men and other key populations
This study is testing two different support programs to see if they can help Black men, transgender individuals, and women who have been involved with the justice system get better access to HIV care and job services.
-
Project SHIELD 2.0: Police Education to Support Public Health in Kentucky
Aimed at police in Kentucky, this program tests whether SHIELD training given to officers, with health workers helping deliver it, can reduce drug-related arrests and steer people who use drugs toward MOUD and other health services.
-
New ways to diagnose lymphoma and multicentric Castleman disease in people living with HIV
This study tests a quick, point-of-care nucleic acid test to help diagnose lymphoma and multicentric Castleman disease in people living with HIV in sub-Saharan Africa.
-
Bridge to Belonging: A Peer‑Led Program to Reduce Loneliness and Depression in older gay and bisexual men with HIV
This program tests a peer-delivered, manualized approach to help men aged 50+ with HIV connect to LGBTQ+-affirming elder services to see if it reduces loneliness and depressive symptoms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.